Pfizer and BioNTech Achieve Health Canada Authorization for Their Vaccine to Combat COVID-19

KIRKLAND, QUEBEC, CANADA and MAINZ, GERMANY, December 9, 2020 (GLOBE NEWSWIRE) — Pfizer Canada and BioNTech SE (Nasdaq: BNTX) today announced that Health Canada has granted Authorization under Interim Order for the emergency use of their mRNA COVID-19 vaccine (BNT162b2). The distribution of the vaccine in Canada will be prioritized according to the populations identified in guidance from the National Advisory Committee on Immunizations (NACI). BioNTech will hold the regulatory approval in Canada, while Pfizer Canada will have the commercialization rights.

Continue reading here:
Pfizer and BioNTech Achieve Health Canada Authorization for Their Vaccine to Combat COVID-19

Related Post